Imunon, Inc. Files Q1 2025 10-Q Report
Ticker: IMNN · Form: 10-Q · Filed: May 12, 2025 · CIK: 749647
| Field | Detail |
|---|---|
| Company | Imunon, INC. (IMNN) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceutical
TL;DR
Imunon (formerly Celsion) Q1 2025 10-Q filed. Financials updated.
AI Summary
Imunon, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Celsion Corp, is based in Lawrenceville, NJ. Financial details for the first quarter of 2025 and comparative periods in 2024 are presented, including common stock, additional paid-in capital, and retained earnings.
Why It Matters
This filing provides investors with an update on Imunon, Inc.'s financial position and performance for the first quarter of 2025, crucial for understanding the company's ongoing operations and potential future value.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Imunon faces inherent risks related to drug development, regulatory approvals, and market competition, which are not fully detailed in this summary financial filing.
Key Numbers
- Q1 2025 — Reporting Period (The first quarter of 2025, for which financial data is reported.)
- 2024 — Comparative Period (Financial data from 2024 is included for comparison.)
Key Players & Entities
- Imunon, Inc. (company) — Filer of the 10-Q report
- Celsion Corp (company) — Former name of Imunon, Inc.
- 20250331 (date) — End of the reporting period
- 20250512 (date) — Filing date of the report
- Lawrenceville, NJ (location) — Business and mail address of Imunon, Inc.
FAQ
What is the primary business of Imunon, Inc.?
Imunon, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was the company formerly known as Celsion Corp?
The company changed its name from Celsion Corp on November 21, 2007.
What is the fiscal year end for Imunon, Inc.?
The fiscal year end for Imunon, Inc. is December 31.
What is the SEC file number for Imunon, Inc.?
The SEC file number for Imunon, Inc. is 001-15911.
What specific financial statement line items are mentioned for the reporting period?
The filing mentions us-gaap:CommonStockMember, us-gaap:AdditionalPaidInCapitalMember, us-gaap:TreasuryStockCommonMember, us-gaap:AccumulatedOtherComprehensiveIncomeMember, and us-gaap:RetainedEarningsMember for the period ending March 31, 2025, and comparative periods.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Imunon, Inc. (IMNN).